Mereo BioPharma Group plc
MREO
$0.24
-$0.01-4.75%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 29.93% | -4.24% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -20.30% | 13.84% | |||
| Operating Income | 20.30% | -13.84% | |||
| Income Before Tax | -4.26% | 8.60% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -4.26% | 8.60% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -4.26% | 8.60% | |||
| EBIT | 20.30% | -13.84% | |||
| EBITDA | 20.64% | -18.76% | |||
| EPS Basic | -4.06% | 8.71% | |||
| Normalized Basic EPS | -3.82% | 8.71% | |||
| EPS Diluted | -4.06% | 8.71% | |||
| Normalized Diluted EPS | -3.82% | 8.71% | |||
| Average Basic Shares Outstanding | 0.22% | 0.17% | |||
| Average Diluted Shares Outstanding | 0.22% | 0.17% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||